Name | Number of supported studies | Average coverage | |
---|---|---|---|
pericyte | 26 studies | 36% ± 19% | |
smooth muscle cell | 24 studies | 33% ± 12% | |
endothelial cell | 18 studies | 29% ± 9% | |
basal cell | 9 studies | 30% ± 14% | |
endothelial cell of vascular tree | 7 studies | 31% ± 9% | |
endothelial cell of artery | 6 studies | 40% ± 11% | |
epithelial cell | 6 studies | 36% ± 15% | |
ciliated cell | 5 studies | 32% ± 24% | |
endothelial cell of lymphatic vessel | 4 studies | 19% ± 3% | |
vein endothelial cell | 4 studies | 30% ± 9% | |
fibroblast | 4 studies | 39% ± 15% | |
kidney distal convoluted tubule epithelial cell | 3 studies | 30% ± 3% | |
myofibroblast cell | 3 studies | 34% ± 21% | |
connective tissue cell | 3 studies | 34% ± 8% | |
keratinocyte | 3 studies | 23% ± 9% |
Insufficient scRNA-seq data for expression of JAG1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 8450.33 | 245 / 245 | 97% | 58.51 | 485 / 502 |
esophagus | 97% | 7953.15 | 1398 / 1445 | 99% | 122.50 | 182 / 183 |
intestine | 99% | 5710.05 | 952 / 966 | 96% | 39.86 | 507 / 527 |
uterus | 100% | 9610.52 | 170 / 170 | 94% | 61.68 | 433 / 459 |
breast | 100% | 9707.33 | 459 / 459 | 91% | 32.30 | 1012 / 1118 |
bladder | 100% | 8272.71 | 21 / 21 | 90% | 52.77 | 452 / 504 |
thymus | 99% | 6552.86 | 649 / 653 | 89% | 29.24 | 537 / 605 |
stomach | 89% | 4116.97 | 321 / 359 | 96% | 40.82 | 274 / 286 |
lung | 99% | 7282.35 | 574 / 578 | 81% | 68.88 | 933 / 1155 |
pancreas | 81% | 2404.19 | 267 / 328 | 97% | 53.29 | 172 / 178 |
kidney | 83% | 3816.54 | 74 / 89 | 89% | 63.42 | 801 / 901 |
ovary | 96% | 5920.44 | 172 / 180 | 66% | 17.26 | 282 / 430 |
skin | 84% | 12435.93 | 1527 / 1809 | 65% | 22.79 | 308 / 472 |
brain | 22% | 583.36 | 594 / 2642 | 78% | 28.21 | 551 / 705 |
adipose | 100% | 11680.37 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 24391.95 | 1335 / 1335 | 0% | 0 | 0 / 0 |
spleen | 99% | 4936.97 | 239 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 77.67 | 44 / 45 |
adrenal gland | 28% | 689.24 | 71 / 258 | 66% | 22.17 | 151 / 230 |
heart | 93% | 3741.99 | 799 / 861 | 0% | 0 | 0 / 0 |
liver | 4% | 104.14 | 9 / 226 | 33% | 14.68 | 136 / 406 |
muscle | 35% | 947.14 | 284 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 28% | 5.11 | 22 / 80 |
lymph node | 0% | 0 | 0 / 0 | 7% | 2.82 | 2 / 29 |
peripheral blood | 4% | 118.73 | 34 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0030216 | Biological process | keratinocyte differentiation |
GO_0001525 | Biological process | angiogenesis |
GO_0001974 | Biological process | blood vessel remodeling |
GO_0097150 | Biological process | neuronal stem cell population maintenance |
GO_0030097 | Biological process | hemopoiesis |
GO_0072017 | Biological process | distal tubule development |
GO_0007219 | Biological process | Notch signaling pathway |
GO_0002011 | Biological process | morphogenesis of an epithelial sheet |
GO_0001709 | Biological process | cell fate determination |
GO_0045446 | Biological process | endothelial cell differentiation |
GO_0061444 | Biological process | endocardial cushion cell development |
GO_0060411 | Biological process | cardiac septum morphogenesis |
GO_0032495 | Biological process | response to muramyl dipeptide |
GO_0042491 | Biological process | inner ear auditory receptor cell differentiation |
GO_0001953 | Biological process | negative regulation of cell-matrix adhesion |
GO_0045599 | Biological process | negative regulation of fat cell differentiation |
GO_0003180 | Biological process | aortic valve morphogenesis |
GO_0061309 | Biological process | cardiac neural crest cell development involved in outflow tract morphogenesis |
GO_0045669 | Biological process | positive regulation of osteoblast differentiation |
GO_0045602 | Biological process | negative regulation of endothelial cell differentiation |
GO_2000241 | Biological process | regulation of reproductive process |
GO_0002085 | Biological process | inhibition of neuroepithelial cell differentiation |
GO_0061073 | Biological process | ciliary body morphogenesis |
GO_0072070 | Biological process | loop of Henle development |
GO_0022408 | Biological process | negative regulation of cell-cell adhesion |
GO_0061101 | Biological process | neuroendocrine cell differentiation |
GO_0045665 | Biological process | negative regulation of neuron differentiation |
GO_0062043 | Biological process | positive regulation of cardiac epithelial to mesenchymal transition |
GO_0050678 | Biological process | regulation of epithelial cell proliferation |
GO_0072006 | Biological process | nephron development |
GO_0035909 | Biological process | aorta morphogenesis |
GO_0045445 | Biological process | myoblast differentiation |
GO_2000737 | Biological process | negative regulation of stem cell differentiation |
GO_0072015 | Biological process | podocyte development |
GO_0061156 | Biological process | pulmonary artery morphogenesis |
GO_0030336 | Biological process | negative regulation of cell migration |
GO_0003184 | Biological process | pulmonary valve morphogenesis |
GO_0045639 | Biological process | positive regulation of myeloid cell differentiation |
GO_0045747 | Biological process | positive regulation of Notch signaling pathway |
GO_0002456 | Biological process | T cell mediated immunity |
GO_0007399 | Biological process | nervous system development |
GO_0042127 | Biological process | regulation of cell population proliferation |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0003215 | Biological process | cardiac right ventricle morphogenesis |
GO_0016324 | Cellular component | apical plasma membrane |
GO_0005576 | Cellular component | extracellular region |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0005912 | Cellular component | adherens junction |
GO_0060090 | Molecular function | molecular adaptor activity |
GO_0005543 | Molecular function | phospholipid binding |
GO_0005112 | Molecular function | Notch binding |
GO_0005198 | Molecular function | structural molecule activity |
GO_0008083 | Molecular function | growth factor activity |
GO_0005509 | Molecular function | calcium ion binding |
GO_0005515 | Molecular function | protein binding |
Gene name | JAG1 |
Protein name | Protein jagged-1 (Jagged1) (hJ1) (CD antigen CD339) Jagged canonical Notch ligand 1 Delta-like protein Jagged 1 |
Synonyms | JAGL1 |
Description | FUNCTION: Ligand for multiple Notch receptors and involved in the mediation of Notch signaling . May be involved in cell-fate decisions during hematopoiesis . Seems to be involved in early and late stages of mammalian cardiovascular development. Inhibits myoblast differentiation (By similarity). Enhances fibroblast growth factor-induced angiogenesis (in vitro). . FUNCTION: Putative Notch ligand involved in the mediation of Notch signaling. . |
Accessions | ENST00000613518.1 P78504 A0A087WXH5 B7U6M8 ENST00000622545.1 Q4KMR2 ENST00000254958.10 [P78504-1] B5M914 A0A087X1E8 B7U6M9 |